---
layout: page
permalink: /publications/index.html
title: Publications
---

> (#: equal contribution, *: corresponding author)

## Publication

- [*The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment*](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1342213/full)<br>***Benqiao Wang***, Ying Zhu, Dan Liu, Chunxiang Hu, Ruixia Zhu*<br>Frontiers in Immunology, Mar, 2024.                    **IF=7.3**<br>PMID: 38605954                    DOI: [10.3389/fimmu.2024.1342213](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1342213/full)<br>

- [*Clinical features of myasthenia gravis with neurological and systemic autoimmune     diseases*](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1223322/full)<br>Ying Zhu#, ***Benqiao Wang***#, Yuehan Hao, Ruixia Zhu*<br>Contribution: literature review<br>Frontiers in Immunology, Sep, 2023.                    **IF=7.3**<br>PMID: 37781409                    DOI: [10.3389/fimmu.2023.1223322](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1223322/full)<br>

- [*Dose-response meta-analysis on urate, gout, and the risk for Parkinson's disease*](https://www.nature.com/articles/s41531-022-00433-5)<br>Hongtao Chang, ***Benqiao Wang***, Yue Shi, Ruixia Zhu*<br>Contribution: literature search, data collection<br>NPJ Parkinson’s Disease, Nov, 2022.                    **IF=8.7**<br>PMID: 36418349                    DOI: [10.1038/s41531-022-00433-5](https://www.nature.com/articles/s41531-022-00433-5)<br>

- [*Advancements and  prospects of novel biologicals for myasthenia gravis: toward  personalized treatment based on autoantibody specificities*](https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1370411/full)<br>Chi Ma, Dan Liu, ***Benqiao Wang***, Yingying Yang, Ruixia Zhu*<br>Contribution: writing–review and editing<br>Frontiers in Pharmacology, May, 2024.               **IF=5.6**<br>PMID: 38881870                    DOI: [10.3389/fphar.2024.1370411](https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1370411/full)<br>

- [*Moderate coffee or tea consumption decreased the risk of cognitive disorders: an     updated dose-response meta-analysis*](https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1370411/full)<br>Ying Zhu, Chunxiang Hu, Xu Liu, Ruixia Zhu* , ***Benqiao Wang***<br>Contribution: formal analysis<br>Nutrition reviews, July, 2023.                                **IF=6.1**<br>PMID: 37523229                   DOI: [10.1093/nutrit/nuad089](https://academic.oup.com/nutritionreviews/article/82/6/738/7234108?login=false)<br>

  <br>

---

## Manuscrips Under Review

- *Comparative Therapeutic Effects and Safety of Different Treatments for Metastatic     Castration-resistant Prostate Cancer: A Systemic Review and Network Meta-Analysis on Antiandrogen, PARP Inhibitor and Immunotherapy*<br>Bohao Jiang# , ***Benqiao Wang***# , Yiming Chen, Yaang Chen, Bohan Li, Jianbin*<br>Contribution: writing, review, editing, methodology<br>**< eClinical Medicine >**<br>Manuscript ID: eclinm-D-24-04075<br>**Current Status**: Revise<br>

  

- *Two Rare Cases of Primary Clear Cell Adenocarcinoma of the Urethra: Clinical     experience, Case report and Literature Review*<br>Bohao Jiang, Jiyuan Hu, ***Benqiao Wang***, Xujia Liu, Yitong Xu, Hao Zhang*<br>**< Frontiers in Oncology >**<br>Manuscript ID:1539312<br>**Current Status**: Independent review<br>

<br>

---

